Blair Jackson
Director of Finance/CFO at ALKERMES PLC
Net worth: 4 M $ as of 30/04/2024
Blair Jackson active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ALKERMES PLC | Director of Finance/CFO | 01/02/2024 | - |
| Chief Operating Officer | 11/01/2021 | 01/02/2024 | |
| Corporate Officer/Principal | 01/05/2016 | 11/01/2021 | |
Alkermes Pharma Ireland Ltd.
 Alkermes Pharma Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Alkermes Plc, Alkermes Pharma Ireland Ltd. is an Irish pharmaceutical company that specializes in developing medicines for addiction, schizophrenia, bipolar I disorder, neurological disorders, and cancer. The company is based in Athlone, Ireland. The company uses a proven R&D approach to develop treatments in the areas of neuroscience and oncology that address real-world, unmet patient needs. | Director/Board Member | - | - |
Synchronicity Pharma, Inc.
 Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Synchronicity Pharma, Inc. discovers, develops and commercializes novel therapeutics. Its products identify components of the circadian system that can be targeted to treat metabolic and related disorders, such as diabetes, obesity, and cardiovascular diseases. The company was founded by Ross S. Bersot, Joseph S. Takahashi, Masashi Yanagisawas and Ron Evans in 2008 and is headquartered in San Jose, CA. | Director/Board Member | 01/10/2018 | - |
Career history of Blair Jackson
Former positions of Blair Jackson
| Companies | Position | Start | End |
|---|---|---|---|
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Director/Board Member | 11/01/2011 | 01/01/2015 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 11/08/2009 | - |
Training of Blair Jackson
| University of Calgary | Undergraduate Degree |
| University of Alberta | Masters Business Admin |
| Massachusetts Institute of Technology | Graduate Degree |
Statistics
International
| United States | 5 |
| Ireland | 3 |
| Canada | 3 |
Operational
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ALKERMES PLC | Health Technology |
| Private companies | 4 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Health Technology |
Alkermes Pharma Ireland Ltd.
Alkermes Pharma Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Alkermes Plc, Alkermes Pharma Ireland Ltd. is an Irish pharmaceutical company that specializes in developing medicines for addiction, schizophrenia, bipolar I disorder, neurological disorders, and cancer. The company is based in Athlone, Ireland. The company uses a proven R&D approach to develop treatments in the areas of neuroscience and oncology that address real-world, unmet patient needs. | Health Technology |
Synchronicity Pharma, Inc.
Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Synchronicity Pharma, Inc. discovers, develops and commercializes novel therapeutics. Its products identify components of the circadian system that can be targeted to treat metabolic and related disorders, such as diabetes, obesity, and cardiovascular diseases. The company was founded by Ross S. Bersot, Joseph S. Takahashi, Masashi Yanagisawas and Ron Evans in 2008 and is headquartered in San Jose, CA. | Health Technology |
- Stock Market
- Insiders
- Blair Jackson
- Experience
